SBIR Banner

You are here

Meet with NCI SBIR PDs in Boston!

September 6, 2017 9:00 AM - 12:30 PM
MIT Koch Institute for Integrative Cancer Research-Auditorium (Room 76-156)
500 Main Street
Cambridge, MA 02142

Meet with NCI SBIR in Boston

Wednesday, September 6, 2017

MIT Koch Institute for Integrative Cancer Research - Auditorium (Room 76-156)

500 Main Street

Cambridge, MA 02142

Sign up now

 

Program directors will discuss the exciting new non-dilutive targeted funding opportunities in cancer focused technology development. They will explain the application and review process at the NIH to help small businesses submit stronger applications. Additionally, the presentation will review the I-Corps at NIH program, and other initiatives run by NCI to facilitate the success of SBIR companies.

 

Following the presentation, selected companies will have the opportunity to meet one-on-one with NCI. To be considered for a one-on-one meeting, please contact NCI SBIR (ncisbir@mail.nih.gov) by Thursday, August 31, 2017 with your name, company name, and a short executive summary of your company as well as the technology project you would like to discuss with the NCI.

 

Speakers:

Michael Weingarten | Director, NCI SBIR Development Center

Andy Kurtz | Team Leader, NCI SBIR Development Center

Ashim Subedee | Program Director, NCI SBIR Development Center

 

Agenda:

     9:00 AM   Registration Opens

     9:30 AM   Presentations and Q&A

   11:15 AM   Networking Lunch

    12:30 PM  Program Close

12:30-3:00 PM  One-on-one Meetings*

 

Topics:

  • NIH/NCI SBIR Overview and Initiatives
  • Funding Opportunities including the FY 2018 Contract Solicitations
  • Tips on Submitting Competitive Applications

 

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on Thursday, August 31, 2017. To be considered for a one-on-one meeting, please contact NCI SBIR (ncisbir@mail.nih.gov), by Thursday, August 31, 2017 with your name, company name, and a short executive summary of your company as well as the technology project you would like to discuss with the NCI.